Medications to treat COVID-19 are in no way a substitute for the vaccine. But under the right circumstances, some show great promise for helping patients.
At the beginning of 2020, most people hadn’t used the word ‘pandemic’ before. Now it’s time to understand the term ‘endemic’ and find out what to expect when COVID changes shape.
Predominantly white perspectives in health practice and policy development can exclude First Nations people in some health services. This is proving evident during the COVID-19 global pandemic.
Vaccine hesitancy has been a subject of intense study in the field of scientific communication. Anti-vaxxers’ recent radicalization needs to be looked at.
The potential risk of easing restrictions will be managed through a continued focus on outdoor activity and greater freedoms only for those who are vaccinated.
An FDA panel has voted against recommending approval of a booster COVID-19 shot for the general population – disappointing some public health officials.
The vaccine-sharing initiative is still without its biggest donor – India – while rich countries are diverting spare doses towards youth and booster programmes.
Between May 2020 and early September 2021, over a quarter of a million more people have died from natural causes than was predicted for that time period.
There are a variety of reasons why people do or don’t want to be vaccinated. Depending on how they frame their messaging around vaccination, doctors can often be the deciding factor.
The term ‘intubation’ is used when experts talk about treating patients with severe COVID-19. But this medical term doesn’t explain the traumatic procedure involved.
Over the course of the pandemic, there’s been an increase in many aspects of social cohesion.
But this may be slipping as lockdowns drag on. Here’s how we measured social cohesion, and why.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand